Vermont Tech Scene
SEE OTHER BRANDS

Exploring the science and technology news of Vermont

Vermont Tech Scene: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vermont Tech Scene.

Press releases published on May 6, 2025

Pourquoi les financiers devraient apprendre le langage DAX

Pourquoi les financiers devraient apprendre le langage DAX

La fonction financière a besoin d’outils de reporting puissants pour suivre l’évolution de son activité de manière rigoureuse. Une maitrise du DAX, le langage de formules intégré au logiciel Microsoft Power BI, permettrait aux financiers d’être autonomes …

Best VPN for Android (2025): IPVanish Awarded Top Mobile VPN by Software Experts

Best VPN for Android (2025): IPVanish Awarded Top Mobile VPN by Software Experts

NEW YORK CITY, May 06, 2025 (GLOBE NEWSWIRE) -- Software Experts has released its annual review of mobile VPN solutions, awarding IPVanish the title of Top Mobile VPN for Android in 2025. The recognition is based on an in-depth evaluation of performance …

ProstaVive Side Effects & Complaints EXPOSED: Real Review Backed by ProstaVive Users’ Experiences!

ProstaVive Side Effects & Complaints EXPOSED: Real Review Backed by ProstaVive Users’ Experiences!

NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Thinking about trying ProstaVive to support your prostate health, energy, and overall wellness? You're definitely not alone. This natural supplement has been generating a lot of buzz, and it’s easy to see why. …

 Italfarmaco Announces U.S. FDA Grants Fast Track Designation to Givinostat in Treatment of Polycythemia Vera

Italfarmaco Announces U.S. FDA Grants Fast Track Designation to Givinostat in Treatment of Polycythemia Vera

MILAN, Italy, May 6, 2025 – Italfarmaco S.p.A. announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to givinostat for the treatment of patients with polycythemia vera (PV), a rare haematologic cancer, for …

Launch of Atigro AI-ERP CEM for Construction & Engineering Management Companies Expands Atigro’s ERP Transformation Industry Leadership

Launch of Atigro AI-ERP CEM for Construction & Engineering Management Companies Expands Atigro’s ERP Transformation Industry Leadership

MCLEAN, Va., May 06, 2025 (GLOBE NEWSWIRE) -- Atigro, a proven ERP transformation firm that leverages its modular augmentation capabilities paired with AI-native frameworks, expanded its industry leadership today with the launch of Atigro AI-ERP CEM for …

ENA Respiratory Appoints International Pharma Experts as Strategic Advisors to Support Development of INNA-051 Antiviral Host Defence Enhancer

ENA Respiratory Appoints International Pharma Experts as Strategic Advisors to Support Development of INNA-051 Antiviral Host Defence Enhancer

MELBOURNE, Australia, May 06, 2025 (GLOBE NEWSWIRE) -- ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defence enhancers to minimize the impact of viral respiratory infections, announces today that it has appointed Kenny …

Microbiotica unveils multiple mechanisms by which MB310, in clinical development for the treatment of ulcerative colitis, protects the intestinal barrier

Microbiotica unveils multiple mechanisms by which MB310, in clinical development for the treatment of ulcerative colitis, protects the intestinal barrier

CAMBRIDGE, United Kingdom, May 06, 2025 (GLOBE NEWSWIRE) -- Microbiotica, a clinical-stage biopharma Company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), has presented new data on the mechanism of …

Iterate.ai and ASA Computers Launch AIcurate, Bringing Secure, On-Prem AI to Enterprises and SMBs

Iterate.ai and ASA Computers Launch AIcurate, Bringing Secure, On-Prem AI to Enterprises and SMBs

SAN JOSE, Calif. and DENVER, May 06, 2025 (GLOBE NEWSWIRE) -- Iterate.ai, whose AI platform enables enterprises to build production-ready applications for private AI requirements and the AI PC era, and ASA Computers, a leading IT solution provider, today …

Essential Pharma strengthens management team with appointment of Duncan Ferguson as Vice President, Commercial

Essential Pharma strengthens management team with appointment of Duncan Ferguson as Vice President, Commercial

Egham, UK – 6th May 2025 – Essential Pharma (“Essential” or “the Company”), a global pharmaceutical company developing and delivering medicines for patients in niche populations, today announces the appointment of Duncan Ferguson as Vice President, …

Angelini Ventures Co-Leads $45 Million Series B Financing of Nuevocor to Advance Transformative Treatment for Genetic Dilated Cardiomyopathy

Angelini Ventures Co-Leads $45 Million Series B Financing of Nuevocor to Advance Transformative Treatment for Genetic Dilated Cardiomyopathy

Angelini Ventures marks its first investment in the cardiovascular and gene therapy space – and first in Asia, further diversifying its strong and growing portfolio Rome, Italy - 6 May 2025 – Angelini Ventures, the corporate venture firm of Angelini …

 Ipsen appoints Laura Réveillon as EVP, Strategy & Transformation

Ipsen appoints Laura Réveillon as EVP, Strategy & Transformation

PARIS, FRANCE, 06 May 2025 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty care-driven biopharmaceutical company, announced today the appointment of Laura Réveillon, PhD as EVP, Strategy …

Ipsen nomme Laura Réveillon au poste de Vice-Présidente Exécutive, Stratégie et Transformation

Ipsen nomme Laura Réveillon au poste de Vice-Présidente Exécutive, Stratégie et Transformation

  PARIS, FRANCE, 6 mai 2025 - Ipsen (Euronext : IPN ; ADR : IPSEY), groupe biopharmaceutique mondial de spécialité, a annoncé aujourd'hui la nomination de Laura Réveillon, PhD, au poste de Vice-Présidente Exécutive, Stratégie et Transformation, à compter …

argenx to Present at BofA Securities 2025 Health Care Conference

argenx to Present at BofA Securities 2025 Health Care Conference

May 6, 2025 Amsterdam, the Netherlands – argenx (Euronext …

Novaremed Announces Completion of Enrollment in NIH-sponsored Phase 2b Study with Non-opioid NRD.E1 for the Treatment of Chronic Pain Associated with Diabetic Peripheral Neuropathy

Novaremed Announces Completion of Enrollment in NIH-sponsored Phase 2b Study with Non-opioid NRD.E1 for the Treatment of Chronic Pain Associated with Diabetic Peripheral Neuropathy

Last patient first visit (LPFV) marks completion of enrollment of 127 adult and elderly patients in the randomized, placebo-controlled trial -- topline data is expected in Q4 2025 This study builds on Phase 2a proof-of-concept results, which showed a …

Correction From Source: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

Correction From Source: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

A correction from source is being issued with respect to the press release titled, Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc., released on May 5, 2025 …

UPCX Staking Airdrop (May 2025): Building the Future of Payments with the Community

UPCX Staking Airdrop (May 2025): Building the Future of Payments with the Community

Singapore, May 05, 2025 (GLOBE NEWSWIRE) -- UPCX is excited to announce the official launch of its latest staking campaign, providing participants with exclusive rewards of up to 7,500 UPC (worth $20,000). The campaign will run from May 2, 2025, to May 30, …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service